Home/Filings/4/0001209191-18-050102
4//SEC Filing

McLoughlin Dennis 4

Accession 0001209191-18-050102

CIK 0001396814other

Filed

Sep 6, 8:00 PM ET

Accepted

Sep 7, 5:00 PM ET

Size

5.7 KB

Accession

0001209191-18-050102

Insider Transaction Report

Form 4
Period: 2018-09-05
McLoughlin Dennis
Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-09-05+20,00020,000 total
    Exercise: $46.55Exp: 2028-08-29Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The stock option vests and becomes exercisable as to 25% of the option shares on August 29, 2019, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Issuer

Pacira Pharmaceuticals, Inc.

CIK 0001396814

Entity typeother

Related Parties

1
  • filerCIK 0001752004

Filing Metadata

Form type
4
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 5:00 PM ET
Size
5.7 KB